- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02529098
Modification in Cortical Activation in Pseudophakic Patients With Visual Difficulties After a Multifocal Implantation (PlainteIMF)
May 27, 2016 updated by: University Hospital, Toulouse
Modification in Cortical Activation by Functional Magnetic Resonance Imaging (fMRI) in Pseudophakic Patients With Visual Difficulties After a Multifocal Implantation
This study will highlight differences in cortical activation between asymptomatic and symptomatic patients.
Study Overview
Study Type
Interventional
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Toulouse, France, 31000
- UHToulouse
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Cataract surgery with an bilateral multifocal lens implant Restor
Symptomatic patients :
- Symptomatic bilateral visual difficulties for 3 months or more after the intervention which impact the daily activity
Asymptomatic patients :
- No visual complaint for 3 months or more after the intervention
Exclusion Criteria:
- Patients with ophthalmology disorders
- Contra indication for fMRI
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Sham Comparator: asymptomatic patients
fMRI Asymptomatic patients
|
functional magnetic resonance imaging
|
Experimental: symptomatic patients
fMRI patients with visual difficulties
|
functional magnetic resonance imaging
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Extent of neural activation in visual cortex measured by the number of voxels
Time Frame: 1 day
|
compare the extent of neural activation in visual cortex between groups
|
1 day
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
extent of neural activation in visual cortex measured by the number of voxels
Time Frame: 1 day
|
compare the extent of neural activation in the different area visual cortex between groups
|
1 day
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Francois Malecaze, professor, University Hospital, Toulouse
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
June 1, 2015
Primary Completion (Anticipated)
July 1, 2016
Study Completion (Anticipated)
July 1, 2016
Study Registration Dates
First Submitted
June 10, 2015
First Submitted That Met QC Criteria
August 18, 2015
First Posted (Estimate)
August 19, 2015
Study Record Updates
Last Update Posted (Estimate)
June 1, 2016
Last Update Submitted That Met QC Criteria
May 27, 2016
Last Verified
May 1, 2016
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 12 523 03
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Vision Disorders
-
The University of Texas Medical Branch, GalvestonCompleted
-
University of Alabama at BirminghamRecruitingLow Vision, Both EyesUnited States
-
Lawson Health Research InstituteUnknownLow Vision Aids | Low Vision, One Eye, Unspecified Eye | Low Vision BlindnessCanada
-
University of California, Los AngelesUniversity of Nebraska; Southern California College of Optometry at Marshall... and other collaboratorsRecruitingLow Vision | Low Vision AidsUnited States
-
Aristotle University Of ThessalonikiRecruitingLow Vision Digital AssistanceGreece
-
Sun Yat-sen University2nd Affilliated Hospital of Fujian Medical UniversityRecruitingArtificial Intelligence | Ophthalmology | Low Vision AidsChina
-
Pamukkale UniversityCompleted
-
Sun Yat-sen UniversityRecruitingArtificial Intelligence | Ophthalmology | Low Vision AidsChina
-
Democritus University of ThraceCompletedPresbyopia | Low Vision | Near VisionGreece
-
VA Office of Research and DevelopmentCompletedCentral Vision Loss From Macular DiseasesUnited States
Clinical Trials on fMRI
-
Weill Medical College of Cornell UniversityMemorial Sloan Kettering Cancer CenterWithdrawnBrain TumorsUnited States
-
Centre Hospitalier Universitaire de Saint EtienneTerminatedMagnetic Resonance Imaging | Neuronal ActivityFrance
-
Centre Hospitalier Universitaire de Saint EtienneUniversity Hospital of Saint-EtienneCompleted
-
Brighton & Sussex Medical SchoolRecruitingDepressionUnited Kingdom
-
Van Boven, Robert W., M.D.Massachusetts Institute of Technology; The Geneva FoundationUnknownTraumatic Brain Injury | Post Traumatic Stress DisorderUnited States
-
Hospices Civils de LyonUniversity of KonstanzCompleted
-
Boston VA Research Institute, Inc.Mclean Hospital; Cambridge Health Alliance; Northeastern UniversityRecruitingSchizophrenia | Treatment-resistant Schizophrenia | Auditory HallucinationUnited States